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a b s t r a c t
As the developing zebraﬁsh pancreas matures, hormone-producing endocrine cells differentiate from
pancreatic Notch-responsive cells (PNCs) that reside within the ducts. These new endocrine cells form
small clusters known as secondary (21) islets. We use the formation of 21 islets in the pancreatic tail of
the larval zebraﬁsh as a model of β-cell neogenesis. Pharmacological inhibition of Notch signaling leads
to precocious endocrine differentiation and the early appearance of 21 islets in the tail of the pancreas.
Following a chemical screen, we discovered that blocking the retinoic acid (RA)-signaling pathway also
leads to the induction of 21 islets. Conversely, the addition of exogenous RA blocks the differentiation
caused by Notch inhibition. In this report we characterize the interaction of these two pathways. We ﬁrst
veriﬁed that signaling via both RA and Notch ligands act together to regulate pancreatic progenitor
differentiation. We produced a transgenic RA reporter, which demonstrated that PNCs directly respond
to RA signaling through the canonical transcriptional pathway. Next, using a genetic lineage tracing
approach, we demonstrated these progenitors produce endocrine cells following inhibition of RA
signaling. Lastly, inhibition of RA signaling using a cell-type speciﬁc inducible cre/lox system revealed
that RA signaling acts cell-autonomously in PNCs to regulate their differentiation. Importantly, the action
of RA inhibition on endocrine formation is evolutionarily conserved, as shown by the differentiation of
human embryonic stem cells in a model of human pancreas development. Together, these results
revealed a biphasic function for RA in pancreatogenesis. As previously shown by others, RA initially plays
an essential role during embryogenesis as it patterns the endoderm and speciﬁes the pancreatic ﬁeld.
We reveal here that later in development RA is involved in negatively regulating the further
differentiation of pancreatic progenitors and expands upon the developmental mechanisms by which
this occurs.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Type I diabetes is a chronic disease caused by the loss of
insulin-expressing β cells, leading to elevated blood glucose levels
(hyperglycemia) and tissue damage. Ultimately, type I diabetics
require insulin therapy. Long-term insulin therapy can be asso-
ciated with serious complications such as inadvertent hypoglyce-
mia and insulin resistance (Donga et al., 2013). β-cell replacement
therapy is a promising way to cure type I diabetes, but its use
is limited by both the paucity of donor islet tissue for transplanta-
tion and problems associated with continuous immunosuppres-
sion (Robertson, 2004). Human embryonic stem cells (hESCs)
and induced pluripotent stem cells (iPSCs) possess the ability to
differentiate into many derivatives of the three primary germ
layers: ectoderm, mesoderm, and endoderm (Murry and Keller,
2008). Progress has been made in generating β cells in vitro from
hESCs and iPSCs (Nostro and Keller, 2012); however, because this
method is still relatively inefﬁcient and has accompanying safety
concerns, this technique is still some way from becoming a cure.
Elucidating mechanisms regulating β-cell development in normal
pancreas helps identify crucial signals that improve the efﬁciency
of generating mature β cells in vitro and could potentially point to
ways of inducing endogenous pancreatic progenitors to differenti-
ate in diabetic patients.
The development of the zebraﬁsh pancreas has been well
studied and is closely conserved with that of the mammalian
pancreas (Kinkel and Prince, 2009; Tiso et al., 2009). The ﬁrst step
of pancreatogenesis is the speciﬁcation of the pancreatic ﬁeld from
nascent foregut endoderm, which in zebraﬁsh occurs in the ﬁrst
day of development. The retinoic acid (RA)-signaling pathway is
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crucial in specifying the pancreatic ﬁeld (Kinkel et al., 2009;
Stafford and Prince, 2002; Stafford et al., 2006). RA is derived
from vitamin A and acts as a ligand for nuclear RA receptors (RARs)
that directly regulate the transcription of downstream target genes
important for development (Rhinn and Dolle, 2012). The distri-
bution and levels of RA in the embryo are tightly controlled
by synthesis enzymes (aldehyde dehydrogenases, Aldhs) and
speciﬁc degradation enzymes of the cytochrome P450 subfamily
(CYP26A1, CYP26B1 and CYP26C1), allowing RA to function like a
morphogen to control the differentiation and patterning of differ-
ent stem and progenitor cell populations (Rhinn and Dolle, 2012).
Neckless (nls) mutant ﬁsh lack Aldh1a2 activity and, as a conse-
quence, RA production is compromised. In nls mutants there is a
dramatic reduction in the number of pancreatic cells formed
(Stafford and Prince, 2002). Conversely, increasing RA-signaling
activity (either by exogenous RA supplement or the removal of
RA-degradation enzymes) leads to an expansion of the pancreatic
ﬁeld (Kinkel et al., 2009; Stafford and Prince, 2002; Stafford et al.,
2006).
By 24 h post fertilization (hpf), dorsal pancreatic endoderm has
coalesced at the midline of the zebraﬁsh embryo to form the
principal islet. In the majority of ﬁsh before 5 days post fertiliza-
tion (dpf), this islet represents the sole location of the pancreatic
endocrine cells (Biemar et al., 2001). These ﬁrst-transition endo-
crine cells of the principal islet possess a low proliferative capacity
and contribute little to the future adult endocrine system
(Hesselson et al., 2009; Wang et al., 2011). Around 32 hpf, ventral
endoderm cells start to express the transcription factor Ptf1a (Lin
et al., 2004; Zecchin et al., 2004) and migrate in a posterior and
dorsal direction to meet and envelop the principal islet and to
create a recognizable pancreas. Around 80 hpf a second wave of
endocrine differentiation (or secondary transition) occurs as
hormone-producing cells differentiate from the extra-pancreatic
duct and contribute to the principal islet (Dong et al., 2007, 2008).
By 5 dpf, the pancreas is elongated and mostly exocrine tissue
derived from the ventral cells, structured with an anterior ‘head’
containing the principal islet and a ‘tail’ containing intrapancreatic
ducts. The ducts contain pancreatic Notch-responsive cells (PNCs).
These PNCs are larval progenitors that differentiate during later
stages of development to form the 21 islets along the duct in the
pancreatic tail (Ninov et al., 2012; Wang et al., 2011). The forma-
tion of such 21 islets in the larval zebraﬁsh pancreas is analogous
to endocrine formation in mammalian pancreas. Both events
involve the differentiation of Notch-responsive ductal-associated
progenitors. For these reasons studying the formation of endocrine
cells of the 21 islets is a promising way to discover new strategies
for β-cell recovery in type I diabetes.
Several different signaling pathways are essential for pancreas
development (Kimmel and Meyer, 2010; Serup, 2012). For
instance, Notch signaling has long been known as central to both
mammalian (Apelqvist et al., 1999; Esni et al., 2004; Hald et al.,
2003; Jensen et al., 2000; Murtaugh et al., 2003) and zebraﬁsh
pancreas development (Esni et al., 2004; Lorent et al., 2004; Ninov
et al., 2012; Parsons et al., 2009; Zecchin et al., 2007). Inhibition of
Notch signaling leads to precocious differentiation of PNCs and the
early appearance of endocrine cell types in the 21 islet position
within the pancreatic tail (Parsons et al., 2009). To ﬁnd pathways
other than Notch signaling that regulate 21 islet formation, we
performed a chemical screen in larval zebraﬁsh from 3 to 5 dpf.
One of the hit compounds we identiﬁed was Tetraethylthiuram
disulﬁde (Disulﬁram, DSF) and this drug was shown to induce
precocious 21 islets by inhibiting the Aldh-dependent production
of RA (Rovira et al., 2011). Conversely, increasing levels of RA
rescued the effects of Notch inhibition by blocking precocious
endocrine differentiation, suggesting RA signaling is also involved
in the regulation of endocrine differentiation. Together, these
results suggested that RA plays a role in endocrine pancreas
differentiation; hence, a pancreatic source of RA should exist.
Previously we showed that the developing larval exocrine pan-
creas (6 dpf) has Aldh enzymatic activity, consistent with RA
production (Rovira et al., 2011). As the larval ﬁsh mature (from
15 dpf), a second potential RA source appears as Aldh1 positive
cells differentiate along the duct from the PNCs. These Aldh1þ
cells are rare at ﬁrst but increase in number with age (Matsuda et
al., 2013).
In this present manuscript, we further characterize the pan-
creatic function of the RA-signaling pathway, and show that RA
signaling cell-autonomously regulates the differentiation of pan-
creatic progenitors during the secondary transition of endocrine
development. Together with the results of other groups, our
results suggest that RA signaling has a biphasic function in
pancreatogenesis. RA is both required for the speciﬁcation of the
embryonic pancreas and later in regulating pancreatic progenitor
differentiation. Using hESC differentiation protocols to model
human pancreas development (Rezania et al., 2012), we demon-
strate that the action of RA inhibition on endocrine progenitor
differentiation is a conserved phenomenon.
Material and methods
Transgenic lines
All transgenic lines used are listed in Supplementary Table S1.
All new transgenic lines were generated as described (Wang et al.,
2011) using the T2KXIGΔIN backbone and Tol2-mediated trans-
genesis (Kawakami, 2004). Two cre drivers were used in this
report that express 4-hydroxytamoxifen (4OHT) inducible cre
(creERT2) and are described in Wang et al. (2011). Tg(Tp1glob:
creERT2)jh12 drives creERT2 in cells undergoing Notch signaling and
is called ‘Notch-responsive creERT2 driver’. Tg(β-actin:GFP-F2A-
creERT2)jh29 drives creERT2 ubiquitously and is called ‘ubiquitous
creERT2 driver’. Two cre-responder lines were utilized: (1) Tg(β-
actin:loxP-stop-loxP-hmgb1-mCherry)jh15, which is used in lineage
tracing and is referred to as ‘nuclear-red cre responder’ (Wang et al.,
2011); and (2) Tg(ubb:loxP-eCFP-loxP-dnRAR-GFP)jh39, a new cre-
responder line utilizing the ubiquitous promoter/enhancer ele-
ment from ubiquitin B (ubb) (Mosimann et al., 2011) and called
‘dnRAR cre responder’. This transgene was generated using a gene
cassette encoding a fusion of dominant-negative zebraﬁsh retinoic
acid receptor α (dnRAR) fused with GFP (gift from K. Poss (Kikuchi
et al., 2011)). Several transgenic lines were used to label speciﬁc
cell types with ﬂuorescent protein expression. Tg(Tp1bglob:hmgb1-
mCherry)jh11 (Notch reporter) labels Notch-responsive cells with
nuclear mCherry. Tg(pax6b:GFP)ulg515 (Delporte et al., 2008) labels
all endocrine cells; Tg(neuroD:GFP)nl1 labels committed endocrine
progenitors (Obholzer et al., 2008). The construct used to label
cells responding to RA signaling, Tg(RARE-cFos:QF; QUAS:GFP), here
called ‘RA reporter’, was made using an oligo containing four copies
of 50-ggttca(n5)agttca-30, each copy separated by 11 nucleotides.
This RA-responsive element (RARE) was cloned upstream of
the cFos minimal promoter and sequence encoding the QF tran-
scriptional activator. Included in the same transgene were the
QF-binding upstream activating sequence (QUAS) and the cFos
minimal promoter, which together regulate transcription of gfp
(Subedi et al., 2014).
In situ hybridization and immunoﬂuorescence
5 dpf larvae were ﬁxed in 4% PFA overnight and in situ hybri-
dization was performed on dissected larval pancreata essentially
as in (Xu et al., 2002). The primer sequences used to generate the
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ribo probes are listed in Supplementary Table S2. Images were
recorded using a Nikon AZ100 microscope. Immunoﬂuorescent
staining (Costa et al., 2003) was performed on dissected larval
pancreata (Parsons et al., 2009). The following antibodies were
used: rabbit polyclonal anti-GFP at 1:200 dilution (A11122, Life
Technologies), anti-Insulin at 1:400 (A0564, Dako), anti-Glucagon
(A0565, Dako) at 1:400, anti-Somatostatin at 1:400 (A0566, Dako),
and ﬂuorescently conjugated 21 antibodies at 1:400 dilution
(Jackson ImmunoResearch Labs INC).
Confocal imaging
Dissected larval pancreata were mounted in ﬂuorescent
mounting medium (Dako) and imaged with a Nikon A1-si Laser
Scanning Confocal Head mounted on a TiE inverted microscope
through a Plan Apo 20 VC (N.A. 0.75) (Nikon). Acquisition and
analysis was performed using NIS-Elements software (Ver 3.22,
build 710). Cell number was quantiﬁed by counterstaining nuclei
with DAPI (0.2 mg/ml) and counted by using NIS-Elements soft-
ware (Nikon).
Drug treatment
Unless otherwise stated in the text, drug treatments were
performed as follows. Compounds were made as 10 mM stocks
in DMSO and diluted to 10 μM Disulﬁram (DSF; 86720, Sigma),
10 μM Diethylaminobenzaldehyde (DEAB; D86256, Sigma), 10 μM
all-trans retinoic acid (RA; R2625, Sigma), and 0.625 μM
RO4929097 (S1575, Selleckchem). 3 dpf Embryos were incubated
in drug until 5 dpf in the dark at 28 1C. As previously shown, 0.5%
DMSO does not signiﬁcantly change secondary islet formation and
is used as a negative control (Rovira et al., 2011). 4-Hydro-
xytamoxifen (4OHT; T176, Sigma) was dissolved in 100% ethanol
to make a 10 mM stock solution. Embryos were incubated in E3
medium (Westerﬁeld, 2000) with 5 μM 4OHT and kept in the dark
at 28 1C for 24 h, then washed in fresh E3. After drug treatment we
either (1) quantiﬁed numbers of 21 islets following in situ hybri-
dization to detect neuroD expression; or (2) used transgenic
markers and confocal microscopy to image and quantify 21 islet
cell numbers.
hESC culture
The H9 hESC line was obtained from the WiCell Research
Institute (Madison, WI), and was treated as per the protocol
established by the Kieffer lab (Rezania et al., 2012). More details
provided in Supplemental Materials and methods.
Results
RA and Notch signaling act together to regulate secondary islet
differentiation
Our lab and others have established the requirement of Notch-
signaling to maintain multi-potent progenitor cells in the pancreas
(Murtaugh et al., 2003; Parsons et al., 2009). More recently, we
demonstrated that the precocious formation of 21 islets can be
induced in zebraﬁsh larvae by reducing levels of endogenous RA
signaling (Rovira et al., 2011). Furthermore, we found that exo-
genous RA can prevent the normal formation of 21 islets that form
in larval ﬁsh (5–8 dpf, Supplemental Fig. S1). This observation is
consistent with a reduction in RA levels being required for 21 islet
formation during normal larval development. Accordingly, we
wanted to determine whether RA and Notch signaling act together
in regulating 21 islet formation. We empirically tested a range of
concentrations for the Notch inhibitor, RO4929097, and ALDH-1
inhibitor, DEAB, to ﬁnd concentrations for each compound that led
to only low levels of precocious 21 islet formation. To assist in
quantifying 21 islet cells we used Tg(neuroD:eGFP)nl1 transgenic
larva in which GFP is expressed in all nascent endocrine cells
(Obholzer et al., 2008). As shown in Fig. 1, treatment with
0.625 μM RO4929097 or 12.5 μM DEAB from 3 to 5 dpf induced
only slightly more 21 islet cells than that appear in negative
controls (2.6970.32 SE po0.02, and 2.0870.29 SE p40.05,
compared to 1.7570.23 SE). Conversely, a combination of both
0.625 μM RO4929097 and 12.5 μM DEAB gave a highly signiﬁcant
difference (8.4970.7 SE, po0.001) when compared to DMSO
Fig. 1. Notch and RA signaling regulate the induction of 21 islet cells in a manner consistent with synergy. (A–D) Confocal z-stack projections of larval Tg(neuroD:GFP)nl1
pancreata dissected at 5 dpf. Larvae were treated with (A) DMSO, (B) RO4929097 (RO) 0.625 μM, (C) DEAB 25 μM and (D) DEAB 25 μMþRO 0.625 μM, from 3–5 dpf. 21 Islet
cells (green) in the tail region of pancreata are indicated by arrowheads. Pancreata are outlined in white dashed lines. Scale Bar, 100 μm. (E) Average number of 21 islet cells
per 5 dpf larval pancreas. N¼number of larval pancreata quantiﬁed. Error Bar represents standard error around the mean (SE). Signiﬁcance, **po0.001.
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treatment, and this amount of 21 islet cells is clearly higher than
just an additive effect of the two compounds (Fig. 1). This result
suggests that the RA and Notch pathways are concordantly acting
in the same pathway to regulate the differentiation of 21 islets. To
further test whether simultaneous or sequential inhibition of
these pathways was most efﬁcacious in 21 islet induction, we
carried out the following four different treatments: (1) RO4929097
and DEAB were added together for one day from 3 to 4 dpf;
(2) both drugs were added for one day from 4 to 5 dpf;
(3) RO4929097 was added for one day (3–4 dpf) before the larvae
were washed and incubated with DEAB for the next day (4–5 dpf);
and, (4) the order of the drugs was reversed, observing the same
time intervals. Induction of 21 islets was quantiﬁed for all condi-
tions and compared to negative controls (DMSO). We only
observed a signiﬁcant induction of 21 islet cells if both drugs were
simultaneously present (either between 3 and 4 or 4 and 5 dpf,
po0.001) (Supplementary Fig. S2). These observations are con-
sistent with RA- and Notch-signaling acting synergistically in the
same developmental pathway to regulate 21 islet formation.
Pancreatic progenitors are RA responsive
We have previously reported ALDH enzymatic activity in larval
exocrine tissue, suggesting there is an endogenous source of RA in
the larval pancreas (Matsuda et al., 2013; Rovira et al., 2011). To
better understand how RA is involved in regulating larval 21 islet
formation, we wanted to determine which cells are responding to
RA signaling. Several RA-signaling reporter lines have been estab-
lished (Perz-Edwards et al., 2001; Waxman and Yelon, 2011). Using
these RA-signaling reporter lines we could not detect any RA-
signaling activity in the larval pancreas (data not shown). We
hypothesized that conventional transgenic reporters do not pro-
vide a level of sensitivity required to detect RA-dependent
transcription in a discrete cell population in the pancreas. We
therefore adopted a bipartite transgenic approach by utilizing the
QF/QUAS system (Potter et al., 2010; Subedi et al., 2014). Our new
construct contains 4 copies of a retinoic acid response element
(RARE) found in murine HoxA1 (Langston et al., 1997). This RARE
regulates expression of the transactivator QF. Also in the same
construct are multimeric binding sites for QF (QUAS) regulating
expression of GFP (Fig. 2A). This bipartite system provides the
potential for ampliﬁcation of the reporter signal without the
caveats of silencing associated with Gal4/UAS methods (Subedi
et al., 2014). The Tg(RARE-cfos:QF;QUAS:GFP) construct was
injected into one-cell embryos to generate a stable transgenic line,
hereafter referred to as the RA reporter. The ability of the RA
reporter line to report on RA signaling was validated by demon-
strating sensitivity to RA levels in the whole larvae (Fig. 2B) and by
showing an expression pattern in early embryogenesis that is
identical to previous reports (Supplementary Fig. S3) (Mandal et
al., 2013; Perz-Edwards et al., 2001; Waxman and Yelon, 2011).
To investigate which cells of the larval (5 dpf) pancreas are
responding to RA signaling we removed and imaged the pancreata
from RA reporter ﬁsh. GFP expression was localized to the principal
islet and intrapancreatic duct regions (Fig. 2C). In keeping with
results seen at the level of the whole organism, reporter expres-
sion in the pancreas is also sensitive to RA level (Fig. 2B insets). In
the absence of exogenous RA, no reporter expression is seen in
acinar cells. When exogenous RA is added, however, we do detect
variegated GFP expression in acinar cells. There are a few explana-
tions for this variegated expression, including (1) the acinar
population is heterogeneous and only some acinar cells have the
capability to respond to RA, albeit at non-physiological RA levels;
and (2) as is well reported, the transgenes maybe undergoing
stochastic silencing in some cells (Stuart et al., 1990). We next
sought to ascertain which ductal cells are RA-responsive. Nkx6.1 is
a marker of PNCs (Supplementary Fig. S4). Utilizing our RA
reporter, we found RA-responsive GFP positive cells in the intra-
pancreatic duct region do indeed express Nkx6.1 (Fig. 2C and Cʹ).
While some Nkx6.1 positive cells express GFP, not all PNCs are
labeled by the transcriptional activity of the RA reporter, demon-
strating either heterogeneity within the PNC population or var-
iegated expression from the transgenic RA reporter (Fig. 2C and Cʹ).
Taken together, our results demonstrate that a signiﬁcant sub-
population of PNCs is responding to endogenous RA.
Inhibition of RA signaling induces PNC differentiation
PNCs are the larval progenitors of ductal cells, centroacinar
cells, and endocrine cells during normal development (Wang et al.,
2011). Furthermore, we have shown that a sub-population of PNCs
is responding to RA signaling. For these reasons, we wanted to
know if the precocious 21 islets induced by inhibiting RA signaling
were also formed from differentiating PNCs. To perform genetic
inducible fate mapping of larval PNCs we utilized ﬁsh transgenic
for (1) our Notch-responsive creERT2 driver; (2) our nuclear-red cre
responder (Fig. 3A); and (3) Tg(pax6b:GFP)ulg515, a line in which
endocrine cells are labeled with green ﬂuorescence (Delporte et
al., 2008). Lineage tracing was performed in these triple transgenic
larvae by activating creERT2 with 4OHT incubation from 2 to 3 dpf
(Fig. 3B). Next, lineage-labeled larvae were incubated from 3 to
5 dpf in either DMSO (control, Fig. 3D) or an ALDH-1 inhibitor
(either DEAB or DSF). When ALDH-1 activity was inhibited with
either DEAB (Fig. 3E) or DSF (Fig. 3F), a proportion of the GFP-
positive 21 islet cells were also labeled with nuclear-red ﬂuores-
cence (Fig. 3Eʹ and Fʹ). The presence of double-labeled cells
indicates that PNCs are contributing to the induced endocrine cell
population. While this method of lineage analysis cannot rule out
the contribution of other cell types to induced 21 islet cells, we can
nevertheless conclude that inhibition of RA signaling directly leads
to the differentiation of PNCs into endocrine cells.
Generation of dnRAR cre responder transgene to inhibit endogenous
RA signaling
In order to inhibit endogenous RA signaling in a cell-speciﬁc
way, we generated a dnRAR cre responder transgene using sequence
encoding a fusion of a dominant-negative form of the zebraﬁsh RA
receptor α and GFP (dnRAR-GFP) (Kikuchi et al., 2011). Using this
transgene we generated the dnRAR cre responder line of ﬁsh, Tg(ubb:
loxP-eCFP-loxP-dnRAR-GFP)jh39. The dnRAR cre responder transgene is
designed to constitutively express dnRAR-GFP following cre recom-
bination (Supplementary Fig. S5A). To validate this dnRAR cre
responder line, we crossed these ﬁsh to a ubiquitous creERT2 driver
line, Tg(β-actin:GFP-F2A-creERT2)jh29 (Wang et al., 2011). The result-
ing double-transgenic larvae had a 4OHT-dependant phenotype
(Supplementary Fig. S5F) reminiscent of aldh1a2nls/nls mutants,
which lack Aldh1a2 activity (Begemann et al., 2001) (Supple-
mentary Fig. S5H). In situ hybridization formyoD and krox20 reveals
aberrant anterior-posterior patterning caused by widespread
dnRAR-GFP expression (Supplementary Fig. S5G) and is consistent
with diminished RA signaling (Supplementary Fig. S5I). We further
demonstrated the utility of the dnRAR cre responder line by crossing
it with our new RA reporter line. As predicted, widespread expres-
sion of dnRAR-GFP dramatically reduced the activity of the RA
reporter (Supplementary Fig. S5J–M).
As mentioned previously, RA-signaling is required for pancreas
ﬁeld speciﬁcation during early development (Kinkel et al., 2009;
Stafford and Prince, 2002; Stafford et al., 2006). To further validate
our dnRAR cre responder line, we looked at the consequences of
inducing early expression of dnRAR-GFP. Again we injected cre
mRNA into one-cell dnRAR cre responder embryos to induce
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widespread expression of dnRAR-GFP (Supplementary Fig. S6A
and B) and examined the formation of pancreatic endocrine and
exocrine tissue by in situ hybridization for ins and trypsin,
respectively. We found that expression of both ins and trypsin
were abrogated following the induction of dnRAR-GFP (Fig. 4C and
D), compared to uninjected controls (Fig. 4A and B) or injected
controls transgenic for a nuclear-mCherry responder (Supplementary
Fig. S6E and F). This observed phenotype is consistent with studies
on either aldh1a2nls/nls mutant or ALDH inhibitor-treated ﬁsh (Alexa
et al., 2009; Stafford and Prince, 2002). Taken together, our results
show that over-expression of dnRAR from the dnRAR cre responder
transgene can functionally block the endogenous RA-signaling path-
way. Hence, we have generated a dnRAR cre responder ﬁsh line that
allows inhibition of endogenous RA signaling in a Cre-dependent
manner.
The RA-signaling pathway has cell-autonomous effects on PNC
differentiation in the formation of 21 islets
From our earlier work we knew that PNCs could be induced to
differentiate to endocrine cells by RA inhibition. To determine
whether RA signaling acts on PNC differentiation in a cell-
autonomous manner we again used the cre/lox system. As pre-
viously reported, in the pancreata of Notch-responsive creERT2 driver
larvae up to 75% of PNCs will undergo cre-dependent recombination
following 4OHT treatment (Wang et al., 2011). Larvae transgenic for
both this driver and the dnRAR cre responderwere treated with 4OHT
from 2 to 5 dpf to induce PNC expression of the dnRAR-GFP fusion
protein. Use of this fusion precludes the use of other GFP reporters;
consequently, the formation of 21 islets was assessed at 5 dpf by the
following methods: (1) in situ hybridization to detect the expression
of the pan-endocrine marker neuroD (Fig. 5A–C); and (2) immuno-
ﬂuorescent detection of all α, β and δ cells (Fig. 5D–G). As in situ
hybridization affords a lower level of resolution, with this method
we were limited to counting the number of 21 islets rather than
individual cells. We found that the average number of 21 islets/
pancreas in 4OHT-treated transgenic larvae (0.9570.12 SE) was
signiﬁcantly increased compared to vehicle-treated larvae
(0.4870.11 SE) (po0.001) (Fig. 5A–C). Using immunoﬂuorescent
detection of hormone-expressing cells (with antibodies to Insulin,
Glucagon and Somatostatin to respectively detect α, β and δ cells),
we quantiﬁed the number of individually induced endocrine cells in
Fig. 2. PNCs are RA-responsive. (A) Schematic of the RA reporter, 4xRARE-cFos:QF; QUAS:GFP. Expression of transcription factor QF (blue arrow) is driven by 4 RA-responsive
elements (4xRARE, 4 red ovals). In the opposite orientation, GFP coding sequence (green arrow) is cloned downstream of 5 QF upstream activating sites (5xQUAS, 5 cyan
ovals). QF binds to QUAS sequence to activate GFP expression. HS4 Insulator sequence (black rectangle) prevents the interference between the two transcriptional units. Pink
rectangles represent cfosminimal promoters. The transgene is ﬂanked by Tol2 arms (gray triangles). (B and C) Fluorescence images of RA reporter larvae. The channel of green
ﬂuorescence shows the RA reporter signal. (B) Compared to DMSO control, 3 dpf larvae treated with exogenous RA or DEAB increase or decrease their RA reporter signal,
respectively. The larvae were incubated from 1–3 dpf with either 10 μM RA, 25 μM DEAB or DMSO. Insets show images of dissected pancreata from treated larvae at 5 dpf,
outlined in white dashed lines. (C) RA-responsive cells are Nkx6.1þ in the larval pancreas. A single-plane confocal image of a larval pancreas dissected at 5 dpf and
immunostained for Nkx6.1 and Insulin. Arrowheads indicate examples of GFPþ Nkx6.1þ cells. Scale bar, 100 μm.
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4OHT-treated transgenic larvae (Fig. 5D–G). Again we found that the
effects of cre-dependent dnRAR expression signiﬁcantly increased
the number of 21 endocrine cells when compared to controls
(1.2970.17 SE 21 islet cells/pancreas vs 0.5870.14 SE, po0.001).
Using immunoﬂuorescent detection, we saw similar numbers of
induced 21 islet cells in 4OHT treated transgenic larvae (where RA
signaling is reduced in just PNCs), as compared to sibling ﬁsh treated
with DEAB (1.1170.21 SE) (where RA production is compromised
throughout the ﬁsh) (Fig. 5F and G). Additionally, use of a ubiquitous
creERT2 driver allowing widespread expression of dnRAR did not
induce a signiﬁcantly different number of 21 islets thanwhen dnRAR
expression was limited to PNCs (data not shown). As cre-activity is
not uniform in all PNCs it is difﬁcult to make direct comparisons
between the effects of pharmacological and transgenic RA inhibition.
Nevertheless it is clear that inhibiting RA signal transduction in just
PNCs is sufﬁcient to obtain precocious 21 islet cells, further support-
ing the hypothesis that the RA-signaling pathway has a cell-
autonomous effect in controlling PNC differentiation.
Inhibition of RA signaling in hESC-derived pancreatic endoderm
promotes production of endocrine cells
To test if the action of RA inhibition is conserved from zebraﬁsh
to human we took advantage of the protocol from the Kieffer
laboratory (Rezania et al., 2012). This method allows the differ-
entiation of pluripotent hESCs to pancreatic cell types by recapi-
tulating in culture the developmental signaling events that occur
during embryonic pancreas formation. This protocol is divided into
4 stages. Each stage has a treatment regimen that mimics a
different stage of pancreas development during embryogenesis
and leads to the formation of hESC-derived cells with the follow-
ing characteristics: stage 1, deﬁnitive endoderm; stage 2, primitive
gut tube; stage 3, posterior foregut; and, stage 4, pancreatic
endoderm and endocrine precursors (Rezania et al., 2012) (see
Supplemental Materials and methods for details). In this protocol,
RA is required for the speciﬁcation of pancreatic lineages in stage
3, but is removed by stage 4. We used this established hESC
differentiation protocol to assess if the suppression of RA signaling
to promote endocrine formation was conserved in humans.
Obviously, for RA inhibition to have any effect on endocrine
differentiation a local source of RA synthesis in stage 4 cultured
hESCs needs to be present. Previous reports have demonstrated
that pancreatic multi-potent progenitors express Aldh1 in E12.5
mouse embryos (Rovira et al., 2010). Therefore, we hypothesized
that stage 4 cultured hESCs also produce their own RA. To test this
hypothesis we detected the percentage of cells with ALDH-
enzymatic activity in stage 4 cultured hESCs using the Aldeﬂuor
Kit (StemCell Technologies). This kit allows the detection of
Fig. 3. Inhibition of RA signaling induces PNCs to differentiate into endocrine cells. (A) Schematic of the nuclear red cre responder, Tg(β-actin:loxP-stop-loxP-hmgb1-
mCherry)jh15. The β-actin promoter/enhancer drives ubiquitous expression. Active Cre induces recombination between the two loxP sites (black triangles) removing the STOP
signal (yellow box) and allowing production of Hmgb1-mCherry, a nuclear-red ﬂuorescent protein. The transgene is ﬂanked by Tol2 arms (gray triangles). (B) Experimental
timeline of 4OHT-dependent fate mapping. 4OHT was applied 2–3 dpf. Larvae were then exposed to drugs from 3–5 dpf. (C–F) Confocal z-stack projections of dissected
pancreata from larvae transgenic for the Notch-responsive creERT2 driver, Tg(Tp1glob:creERT2)jh12, the nuclear red cre responder and the endocrine marker, Tg(pax6b:eGFP)ulg515.
These triple transgenic larvae were treated with vehicle (C), 4OHTþDMSO (D), 4OHTþDEAB (E), and 4OHTþDSF (F). The presence of lineage-traced cells (red nuclei) is
dependent on 4OHT treatment (D–F). 21 islet cells can be detected in the tail region of larval pancreata after treatment with either DEAB (E) or DSF (F). (E0 and F0) The
precocious 21 islet cells are positive for both GFP and mCherry, indicating their PNC origin. Nuclei are counterstained with DAPI (blue). White dashes outline pancreata. Scale
Bar, 100 μm.
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endogenous ALDH activity by ﬂuorescently labeling the ALDH
active cells, which can then be quantiﬁed by ﬂow cytometry (see
Supplemental Materials and methods for details). A negative
control of cells co-treated with DEAB to inhibit ALDH activity is
used to obtain the level of background ﬂuorescence. As shown in
Figs. 6A, 70.1% of stage 4 cells have ALDH activity, suggesting that a
potential source of endogenous RA indeed exists. Maintaining
levels of exogenous RA through stage 4 resulted in a lower
proportion of cells with ALDH activity (56.2%, Fig. 6B), consistent
with a negative feedback mechanism regulating ALDH1 positive
cell numbers.
Next, we wanted to ask what the effects of inhibiting RA synthesis
are on the production of hormone-positive endocrine cells. We
compared samples of stage 4 cells cultured following the reported
protocol (Rezania et al., 2012) (used as control) to samples in which
1 mM DEAB was added during stage 4. This experiment was repeated
4 times with 3 biological replicates for each condition (n¼12). By
using quantitative RT-PCR (see Supplemental Materials and methods
for details), we demonstrated that after DEAB treatment the levels of
mRNAs encoding for endocrine hormones (such as insulin (INS),
glucagon (GCG) and somatostatin (STT)) are signiﬁcantly increased
compared to controls, with fold increases of 6.2770.69 SE, po0.001;
6.1670.79 SE, po0.001 and 2.6770.3 SE, po0.05 respectively
(Fig. 6C). We then quantiﬁed hESC-derived cells expressing INS or
GCG cultured with or without 1 mM DEAB at the end of stage 4 to
ascertain if the increase in transcripts corresponded to an increase in
endocrine cell numbers. We observed a 1.8670.12 SE fold increase
(po0.005) in the number of INS positive cells following DEAB
treatment compared to cells cultured following the normal stage
4 protocol (Fig. 6D and E). We also quantiﬁed the number of
polyhormone-producing cells in the presence and absence of DEAB,
but did not detect a signiﬁcant difference (data not shown). These
results demonstrate that inhibition of endogenous RA signaling during
stage 4 of hESC differentiation signiﬁcantly increases the number of
Fig. 4. Overexpression of dnRAR blocks pancreatic ﬁeld speciﬁcation. (A–D) The
results of whole mount in situ hybridization to detect ins and trypsin expression in,
dnRAR cre responder transgenic larvae at 72 hpf. Expression of ins and trypsin
demonstrates normal pancreatic ﬁeld speciﬁcation. (A and B) Negative control
larvae (CT). (C and D) Larvae previously injected with cre mRNA at the one-cell
stage and displaying the failure of pancreas speciﬁcation in presence of cre-
dependent dnRAR-GFP. Arrows indicate the location of larval pancreata.
Fig. 5. PNC differentiation is regulated by endogenous RA signaling. (A and B) in situ hybridization for neuroD expression to detect 21 islets in 5 dpf pancreata from larvae
transgenic for both the Notch-responsive creERT2 driver, Tg(Tp1glob:creERT2)jh12, and the dnRAR cre responder, Tg(ubb:loxP-eCFP-loxP-dnRAR-GFP)jh39. These larvae had been
incubated at 2 dpf with either vehicle (A) or 4OHT (B). (C) Average number of 21 islets/pancreas in vehicle or 4OHT treated larvae calculated by counting neuroD expressing
islets. (D–G) Fluorescence immunostaining to detect hormone-expressing cells (insulinþ/glucagonsþ/somatostatinþ), facilitating quantiﬁcation of 21 islet cells in larvae that
were treated from 2–5 dpf with either vehicle (D), or 4OHT (E), or vehicleþDEAB (F). (E″) enlarged image of (E0). (G) Average number of 21 islet cells/pancreas in vehicle,
4OHT, and vehicleþDEAB treated larvae calculated by counting for the number of hormone-expressing cells. **po0.001. White dashes outline pancreata. 21 Islets in the tail
region of the pancreas are indicated by arrowheads. N¼number of larval pancreata quantiﬁed. Error Bar¼SE. Scale Bar, 100 μm.
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endocrine cells, (especially INS positive cells). In conclusion, our results
with differentiating hESCs are consistent with our ﬁndings in the
larval zebraﬁsh pancreas, and demonstrate a novel and conserved
function for RA signaling in regulating endocrine differentiation.
Discussion
Retinoic acid signaling is necessary for the formation of
pancreatic endoderm, as has been demonstrated by others in both
animal models (Chen et al., 2004; Kinkel et al., 2009; Martin et al.,
2005; Ostrom et al., 2008; Penny and Kramer, 2000; Stafford et al.,
2004, 2006; Stafford and Prince, 2002; Tulachan et al., 2003) and
in hESC in vitro differentiation (D’Amour et al., 2006; Jiang et al.,
2007; Johannesson et al., 2009; Kroon et al., 2008; Rezania et al.,
2012, 2013; Zhang et al., 2009). In zebraﬁsh embryos, RA is
synthesized in the anterior trunk mesoderm (8–13 hpf) and
patterns the overlaying RAR-expressing endoderm to become the
pancreatic anlagen (Stafford and Prince, 2002). As in other models,
Fig. 6. Endogenous RA impedes endocrine cell differentiation from hESC-derived pancreas cells. (A) Flow cytometric analysis of endogenous ALDH activity in stage 4 hESCs.
Cells were incubated with Aldeﬂuor reagent in the absence (black line) or presence (gray line) of the ALDH inhibitor (DEAB), then washed before being analyzed for
ﬂuorescence and quantiﬁed by ﬂow cytometry. Graph shows distribution of cells (% of Max) against relative ﬂuorescent intensity. % of Max is calculated from (the number of
cells in an event)/(the number of cells in the maximum event). (B) Flow cytometric analysis of ALDH activity in stage 4 hESCs with additional exogenous RA. (C) Quantitative
RT-PCR to detect expression of hormone genes. During stage 4 of hESC differentiation, 1 mM DEAB was added to inhibit the endogenous synthesis of RA, while non-treated
cells were used as a control (labeled as “Stage 4”). DEAB-treated samples (black bars) were normalized to the controls (gray bar). (D) Quantiﬁcation of the number of
hormone-producing endocrine cells (GCGþ , or INSþ cells). Shown are numbers of cells in DEAB-treated samples normalized to the controls. *po0.05, ***po0.005.
(E) Confocal images of the differentiated hESCs after immunostaining for GCG and INS. Scale Bar, 50 μm.
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RA promotes the formation of pancreas in early development and
thus ultimately the generation of insulin producing β cells (Kinkel
and Prince, 2009). Conversely, impeding RA signaling early in
development, either by pharmacological inhibition (DEAB) (Alexa
et al., 2009; Martin et al., 2005), mutations in aldh1a2 (Alexa et al.,
2009; Martin et al., 2005), or by overexpression of dnRAR, results
in the loss of all pancreatic markers. All these previous studies
were focused on early embryonic events (around 12 hpf) during
stages when the pancreatic ﬁeld is speciﬁed from nascent endo-
derm. In this report, we have presented new evidence that later on
in development (3–5 dpf) RA signaling negatively regulates the
differentiation of PNCs during organogenesis and expands upon
the developmental mechanisms by which this function is realized.
Using our new QF/QUAS based RA reporter, we were able to detect
RA signaling in PNCs. We also showed that RA signaling opposes
PNC differentiation and endocrine cell formation in a cell-
autonomous manner. We conclude, therefore, that RA has a
biphasic function in regulating the formation of endocrine cells
in the larval pancreas (Fig. 7): (1) RA is required for pancreatic ﬁeld
speciﬁcation during the early stages of pancreas development; and
(2) RA negatively regulates PNC differentiation at the secondary
transition of larval pancreas.
Besides RA signaling, several other pathways have been shown
to be essential for pancreas development (Kimmel and Meyer, 2010;
Serup, 2012). Notch signaling is one such pathway, and it is known
to negatively regulate the differentiation of pancreatic progenitors.
In this present study, we demonstrated that the Notch- and RA-
signaling pathways act in a manner consistent with synergy and
regulate PNC differentiation, suggesting that there is a common
downstream target shared by both cascades. This interaction needs
further investigation; however, some clues to potential mechanisms
can be inferred from the published research of others. Müller et al.
were interested in how RA blocked proliferation in a breast cancer
cell line, and their discoveries demonstrated that RA up-regulated
expression of the transcription factor SOX9 (Muller et al., 2010). It is
known that Notch signaling directly regulates Sox9 expression in
pancreatic progenitors, both in mouse (Sox9) (Shih et al., 2012) and
in zebraﬁsh (sox9b) (Delous et al., 2012). Furthermore, Sox9 not only
marks pancreatic progenitors, but also is essential in regulating
progenitor differentiation in both mice and zebraﬁsh (Lynn et al.,
2007; Seymour et al., 2007). Thus, Sox9 represents a promising
candidate as a downstream target of both Notch- and RA-signaling
pathways in pancreatic progenitors. Future work will test whether
the action of RA signaling regulates PNC differentiation in a Sox9b
dependent manner.
Following from our zebraﬁsh research, we wanted to determine
if the function of RA in the later stages of pancreas development
was conserved in humans. To test the effects of RA signaling on
human pancreas development, we utilized the in vitro differentia-
tion of hESCs to pancreatic endocrine hormone-producing cells.
These pluripotent stem cells can be induced to differentiate along
different development programs and produce a wide variety of cell
types (Thomson et al., 1998). We selected the Kieffer laboratory
protocol for its efﬁciency and reproducibility on different com-
mercially available hESC lines (Rezania et al., 2012). In this
protocol, as with speciﬁcation of the pancreatic anlage in the
embryo, RA is required in stage 3 to drive differentiation of hESC-
derived cells with characteristics of gut-tube endoderm to cells
with characteristics reminiscent of posterior foregut (D’Amour et
al., 2006). In the last step of this protocol during the differentiation
of cells with pancreas progenitor characteristics to endocrine cell
fates (stage 4), exogenous RA is not added to the culture media.
Instead, we showed that during stage 4, hESC derived cells are
capable of synthesizing RA themselves. The majority of stage
4 cells possess ALDH enzymatic activity and can utilize the RA
synthesis substrate retinol (vitamin A) found in the B-27 serum
supplement used in the media.
In this present study, we did not address if cells reminiscent of
PNCs exist during the hESC differentiation protocol or if human
equivalent cells give rise in vitro to hormone-positive endocrine
cells. However, others have clearly shown that as hESCs differ-
entiate, numerous cells express the endocrine precursor and PNC
marker, NKX6.1. These NKX6.1 positive cells form before the
appearance of hormone-expressing endocrine cells (D’Amour et
al., 2006; Rezania et al., 2013). This observation suggests a
common differentiation progression in the developing pancreatic
endoderm of both zebraﬁsh larvae and differentiating hESCs. Of
potential therapeutic importance, we showed that inhibition of RA
synthesis by DEAB treatment during stage 4 of hESC differentiation
signiﬁcantly enhances hormone-producing cell production. Our
results with this in vitro model of human pancreas development
demonstrate that, as in larval zebraﬁsh, inhibition of RA signaling
promotes the differentiation of endocrine cells from pancreatic
progenitors.
When stage 3 levels of exogenous RA were maintained at stage
4 of hESC differentiation, the proportion of cells with ALDH activity
Fig. 7. Proposed model of the biphasic function of RA signaling in the development of the pancreas. The pancreatic ﬁeld is speciﬁed from the nascent endoderm by RA at
very early stages of development (5–7 Somites (S)). Exogenous RA treatment expands the pancreatic ﬁeld. In the dorsal bud, Notch signaling inhibits the formation of
endocrine cells in the primary transition to form the principal islet. The ducts contain pancreatic Notch-responsive cells (PNCs), which express Sox9b. PNCs are larval
progenitors contributing to the formation of 21 islets, which form the majority of endocrine tissue in adult pancreas. A subpopulation of these pancreatic progenitors also
respond to RA signaling. Inhibition of RA signaling leads to precocious formation of the 21 islets. RA and Notch signaling synergistically regulate the differentiation of
pancreatic progenitors.
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was signiﬁcantly reduced (Fig. 6B). The fact that elevated RA levels
lead to fewer cells capable of making RA implies that a feedback
mechanism is operating to regulate the production of ALDH
expressing cells. This observation is reminiscent of Aldh1-
expressing cells in the juvenile zebraﬁsh pancreas. As the larval
pancreas matures (after 15 dpf), Aldh1-expressing cells start to form
from ductal epithelial cells (Matsuda, et al., 2013). These cells are a
likely new source of RA. Inhibition of Aldh1 enzymatic activity with
DEAB increases the number of these Aldh1 positive cells (Matsuda,
et al., 2013). This result also supports the hypothesis that RA levels
regulate numbers of Aldh positive cells in the pancreas.
To date there is no in vitro protocol that can produce mature,
glucose-sensitive β cells in a manner pure enough to be safe for
transplantation into diabetic humans. Experiments in mice, how-
ever, have demonstrated that mature, glucose-responsive β cells
can be formed in vivo using transplantation of hESC-derived cells
consisting of endocrine precursors and poly-hormonal endocrine
cells (Kroon et al., 2008). Such transplantations into diabetic mice
can even alleviate hyperglycemia, but such in vivo differentiation
requires a signiﬁcant period of time before normoglycemia is
reached (Bruin et al., 2013; Rezania et al., 2012). Any additional
modiﬁcations to current protocols that ultimately enrich the yield
of β cells or reduce heterogeneity of the ﬁnal cell population would
be advantageous. Methods to differentiate hESCs to a pancreatic
fate were developed by understanding signaling events during
embryogenesis. These protocols can be further improved by
applying what can be learned from later signaling events during
organogenesis, such as those described here and elsewhere.
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